You are here
- Home
- Drug Products
- All Drug Products
A Multicenter, Rand., Double-blind, Parallel-group, Pbo-controlled Study of the Efficacy and Safety of SEROQUEL XR Compared with Pbo as an Adjunct to Treatment in Patients with Generalized Anxiety Disorder who Demonstrate Partial or No Response to a SSRI or SNRI Alone or in Combination with a Benzo.
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Sep 1, 2005
- Study Name
- D144300000
- Study Id
- D144300000
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
